case_images: PMC10702249_01
case_images: Baseline chest CT w/contrast in March 2020 before SARS-CoV-2 infection (A and B).
case_images: 10.1177_11795476231210142-fig1.jpg
case_images: PMC10702249_01_10.1177_11795476231210142-fig1.jpg
case_images: fig1-11795476231210142
case_images: Follow-up chest X-ray and CT chest (Figure 1A and B) showed stable PLC with significant regression in the size of axillary and mediastinal lymph nodes and bilateral breast tumors.
case_images: Diagnostic chest CT showing multiple bilateral ground glass airspace opacities (Blue arrows), Left pleural effusion (Red arrow), and mild pericardial effusion (Orange arrow) in June 2020.
case_images: 10.1177_11795476231210142-fig2.jpg
case_images: PMC10702249_01_10.1177_11795476231210142-fig2.jpg
case_images: fig2-11795476231210142
case_images: Chest X-ray revealed intermittent development of left lower lobe airspace opacity and mild to moderate left-sided pleural effusion. Chest CT (Figure 2) also showed multiple bilateral ground-glass airspace opacities consistent with COVID-19 pneumonia.
case_images: Post-COVID-19 infection follow-up chest CT scan showing significant improvement and resolution of pulmonary infiltrates (Blue arrows) and left pleural effusion (Red arrow) in October 2020.
case_images: 10.1177_11795476231210142-fig3.jpg
case_images: PMC10702249_01_10.1177_11795476231210142-fig3.jpg
case_images: fig3-11795476231210142
case_images: Two months after discharge, the CT scan of the chest (Figure 3) showed partial response in primary and metastatic sites.